Sign inGet started

Machatha Stephen

Insider CIK 1836354 · ALDX Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALDX Aldeyra Therapeutics, Inc. S Sale2025-08-112025-08-1322,073$5.15 $113.7K221,799SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2025-03-042025-03-06202,427— $0202,427SEC↗
ALDX Aldeyra Therapeutics, Inc. S Sale2024-08-122024-08-1416,041$4.74 $76.0K236,771SEC↗
ALDX Aldeyra Therapeutics, Inc. S Sale2024-03-122024-04-1711,537$3.16 $36.5K252,812SEC↗
ALDX Aldeyra Therapeutics, Inc. S Sale2024-03-122024-03-1211,537$3.16 $36.5K243,495SEC↗
ALDX Aldeyra Therapeutics, Inc. S Sale2024-03-112024-03-1218,231$3.41 $62.2K255,032SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2024-03-092024-03-12405,450— $0405,450SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2023-02-282023-03-02220,258— $0220,258SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2022-07-152022-07-1969,473— $069,473SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award2022-07-152022-07-19185,605— $0273,263SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2022-03-302022-04-01250,000— $0250,000SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award2022-03-302022-04-0164,395— $087,658SEC↗
ALDX Aldeyra Therapeutics, Inc. A Award deriv2021-04-122021-04-14116,201— $0116,201SEC↗